Mark Schoenberg - 03 Feb 2026 Form 4 Insider Report for UroGen Pharma Ltd. (URGN)

Role
Chief Medical Officer
Signature
/s/ Jason D. Smith, Attorney-in-Fact
Issuer symbol
URGN
Transactions as of
03 Feb 2026
Net transactions value
-$145,174
Form type
4
Filing time
04 Feb 2026, 19:37:34 UTC
Previous filing
03 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Schoenberg Mark Chief Medical Officer 400 ALEXANDER PARK DRIVE, PRINCETON /s/ Jason D. Smith, Attorney-in-Fact 04 Feb 2026 0001763581

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction URGN Ordinary Shares Sale $36,308 -1,844 -1.2% $19.69 150,514 03 Feb 2026 Direct F1
transaction URGN Ordinary Shares Sale $36,289 -1,843 -1.2% $19.69 148,671 03 Feb 2026 Direct F1
transaction URGN Ordinary Shares Sale $72,577 -3,686 -2.5% $19.69 144,985 03 Feb 2026 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units.